IBD
Myths and Misconceptions in the Management of Elderly Patients With Inflammatory Bowel Disease
Feature
Glucagon-Like Peptide-1 Receptor Agonist Use Before and After Liver Transplant
Abstract: Metabolic dysfunction, manifesting as obesity, type 2 diabetes mellitus (T2DM), and related cardiometabolic comorbidities, has emerged as a major driver of morbidity among patients with […]
From Recent Issues
Feature
Therapeutic Drug Monitoring in Adolescents and Children With Inflammatory Bowel Disease
Abstract: Proactive longitudinal therapeutic drug monitoring (TDM) is the standard of care for pediatric patients with inflammatory bowel disease (IBD). This is important because children and […]
Feature
Glucagon-Like Peptide-1 Receptor Agonist Use Before and After Liver Transplant
Abstract: Metabolic dysfunction, manifesting as obesity, type 2 diabetes mellitus (T2DM), and related cardiometabolic comorbidities, has emerged as a major driver of morbidity among patients with […]
Feature
New Developments in the Treatment of Hepatitis B Virus Infection
Abstract: Chronic hepatitis B virus (HBV) infection remains a serious global public health concern and a leading cause of liver cirrhosis and hepatocellular carcinoma. Although currently […]
Supplements
Highlights in Crohn’s Disease From DDW 2026
A Review of Selected Presentations From Digestive Disease Week 2026 May 2-5, 2026 • Chicago, Illinois Risankizumab Reduces Symptoms and Concomitant Therapy Use and Improves Health-Related […]
Highlights in Ulcerative Colitis From DDW 2026
A Review of Selected Presentations From Digestive Disease Week 2026 May 2-5, 2026 • Chicago, Illinois Efficacy and Safety of Guselkumab for Ulcerative Colitis Through Week […]
QOL-Guided Decision-Making to Switch Mechanism of Action in IBS-C: Applying JUST ASK Study Principles in Clinical Practice
About the Patient JS, a 38-year-old man, presented with long-standing complaints of persistent bloating, abdominal distension, constipation, incomplete evacuation, and reduced quality of life. He had […]